Pono Capital (NASDAQ:PONO) announced this afternoon that it has mutually terminated its combination with cannabinoid drug developer Benuvia.
While today’s press release did not provide much detail, Pono Capital intends to continue its search for a target for its business combination and extended its transaction timeline today by three months. The SPAC originally had a deadline of August 13, 2022, but will now have until November 11, 2022 to find a new target and close.
Pono raised $100 million at IPO on August 11, 2021 and initially set out to combine with a disruptive technology company in China or Japan in the area of consumer electronics. The tech-focused SPAC is led by CEO and Founder Dustin Shindo, Chief Strategy Officer Dr. Hank Wuh and CFO Trisha Nomura.
CEO and Founder Dustin Shindo is also Chairman of Pono Capital Two (NASDAQ:PTWOU), one of six SPACs that filed to IPO in June. Pono Capital Two priced its $100 million IPO just last week on August 4, and intends to also focus on disruptive tech targets in Japan.
The termination comes several months after the $440 million deal announcement, which was originally announced on March 18. Pono’s deal with Benuvia was not supplemented with a PIPE and did not have a minimum cash closing condition. The Arizona-based company owns an FDA approved cannabinoid drug SYNDROS (dronabinol oral solution CII), and synthetic cannabinoid manufacturing facilities in the U.S.
One of the eternal questions surrounding SPACs has been their ability or inability to match the opportunity and the performance of the traditional IPO route, and it has become received wisdom on Wall Street that SPACs don’t match up. This is ostensibly born out in in the aggregate statistics that are frequently cited. But, downside...
At the SPAC of Dawn Despite the specter of recession looming, many of the hot technology sectors that SPACs favored during the boom times appear to be coming back on the menu. Ares II (NYSE:AACT) is reportedly angling to lock down a deal with an autonomous trucking firm. Northern Genesis II and Reinvent Y each...
Cantor Equity Partners II (NASDAQ:CEPT) filed another warrantless SPAC showing that the firm will not be slowing down despite Cantor CEO Howard Lutnick moving his attentions to the administration. The new $200 million SPAC would join Cantor Equity Partners I (NASDAQ:CEPO), which became the first SPAC to IPO this year and Cantor Equity Partners (NASDAQ:CEP),...
At the SPAC of Dawn US market futures continue to be flash dark red after a major down day saw SPAC-favorite exchange Nasdaq lose about -4% of its value leaving it running down -9.5% on the year. The sudden downturn has been somewhat personal for the administration as Trump Media (NASDAQ:DJT) itself fell about -11.5%...
Titan Acquisition Corp has filed for a $240 million SPAC IPO, aiming to focus on opportunities in the finance and tech-enabled services industry. The blank-check company intends to list on the Nasdaq under the symbol “TACHU”, offering 24,000,000 units at $10.00 each, with the trust funded at 100.5%. The unit structure includes one-half of one...